14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $34.24 $40.91 Thursday, 25th Apr 2024 COLL stock ended at $35.84. This is 1.01% more than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 2.74% from a day low at $35.05 to a day high of $36.01.
90 days $31.34 $40.91
52 weeks $20.84 $40.91

Historical Collegium Pharmaceutical prices

Date Open High Low Close Volume
Oct 25, 2023 $21.65 $21.98 $21.56 $21.88 197 608
Oct 24, 2023 $21.35 $21.76 $21.15 $21.75 252 624
Oct 23, 2023 $21.28 $21.46 $20.96 $21.26 272 170
Oct 20, 2023 $21.34 $21.57 $21.21 $21.47 348 060
Oct 19, 2023 $21.63 $21.65 $21.06 $21.19 192 456
Oct 18, 2023 $21.74 $22.14 $21.52 $21.75 187 886
Oct 17, 2023 $22.00 $22.26 $21.78 $21.96 193 661
Oct 16, 2023 $21.89 $21.96 $21.60 $21.95 194 932
Oct 13, 2023 $22.74 $22.74 $21.61 $21.90 384 799
Oct 12, 2023 $23.52 $23.52 $22.59 $22.78 215 928
Oct 11, 2023 $23.55 $23.95 $23.20 $23.43 151 126
Oct 10, 2023 $23.53 $23.85 $23.44 $23.74 170 748
Oct 09, 2023 $23.51 $23.75 $23.40 $23.49 113 623
Oct 06, 2023 $23.01 $23.63 $22.82 $23.60 266 639
Oct 05, 2023 $23.72 $23.96 $22.94 $23.02 297 372
Oct 04, 2023 $22.75 $23.63 $22.65 $23.58 556 636
Oct 03, 2023 $22.59 $22.97 $22.36 $22.77 212 766
Oct 02, 2023 $22.32 $22.83 $22.26 $22.76 230 927
Sep 29, 2023 $22.65 $22.65 $22.27 $22.35 252 940
Sep 28, 2023 $22.40 $22.99 $22.33 $22.60 211 876
Sep 27, 2023 $22.12 $22.61 $21.99 $22.35 303 246
Sep 26, 2023 $22.30 $22.81 $22.00 $22.08 318 076
Sep 25, 2023 $22.12 $22.61 $22.10 $22.35 192 482
Sep 22, 2023 $22.52 $22.61 $21.96 $22.26 155 574
Sep 20, 2023 $22.69 $23.20 $22.56 $22.78 170 893
Click to get the best stock tips daily for free!

About Collegium Pharmaceutical

Collegium Pharmaceutical Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatm... COLL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT